Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

The contribution of cholesterol and epigenetic changes to the pathophysiology of breast cancer.

Munir MT, Ponce C, Powell CA, Tarafdar K, Yanagita T, Choudhury M, Gollahon LS, Rahman SM.

J Steroid Biochem Mol Biol. 2018 May 4. pii: S0960-0760(17)30410-7. doi: 10.1016/j.jsbmb.2018.05.001. [Epub ahead of print] Review.

PMID:
29733910
2.

Protective properties of n-3 fatty acids and implications in obesity-associated breast cancer.

Al-Jawadi A, Moussa H, Ramalingam L, Dharmawardhane S, Gollahon L, Gunaratne P, Layeequr Rahman R, Moustaid-Moussa N.

J Nutr Biochem. 2018 Mar;53:1-8. doi: 10.1016/j.jnutbio.2017.09.018. Epub 2017 Oct 4. Review.

PMID:
29096149
3.

Uptake of 3-iodothyronamine hormone analogs inhibits the growth and viability of cancer cells.

Rogowski M, Gollahon L, Chellini G, Assadi-Porter FM.

FEBS Open Bio. 2017 Mar 6;7(4):587-601. doi: 10.1002/2211-5463.12205. eCollection 2017 Apr. Erratum in: FEBS Open Bio. 2017 May 22;7(6):887.

4.

Anti-HIV Factors: Targeting Each Step of HIV's Replication Cycle.

Colomer-Lluch M, Gollahon LS, Serra-Moreno R.

Curr HIV Res. 2016;14(3):175-82. Review.

PMID:
26957194
5.

ERα Mediates Estrogen-Induced Expression of the Breast Cancer Metastasis Suppressor Gene BRMS1.

Ma H, Gollahon LS.

Int J Mol Sci. 2016 Jan 26;17(2). pii: E158. doi: 10.3390/ijms17020158.

6.

ZSCAN4 and TRF1: A functionally indirect interaction in cancer cells independent of telomerase activity.

Lee K, Gollahon LS.

Biochem Biophys Res Commun. 2015 Oct 30;466(4):644-9. doi: 10.1016/j.bbrc.2015.09.107. Epub 2015 Sep 25.

PMID:
26403970
7.

Establishment, characterization, and toxicological application of loggerhead sea turtle (Caretta caretta) primary skin fibroblast cell cultures.

Webb SJ, Zychowski GV, Bauman SW, Higgins BM, Raudsepp T, Gollahon LS, Wooten KJ, Cole JM, Godard-Codding C.

Environ Sci Technol. 2014 Dec 16;48(24):14728-37. doi: 10.1021/es504182e. Epub 2014 Dec 3.

PMID:
25384208
8.

Zscan4 interacts directly with human Rap1 in cancer cells regardless of telomerase status.

Lee K, Gollahon LS.

Cancer Biol Ther. 2014 Aug;15(8):1094-105. doi: 10.4161/cbt.29220. Epub 2014 May 19.

9.
10.

Chromosomal evolution among leaf-nosed nectarivorous bats--evidence from cross-species chromosome painting (Phyllostomidae, Chiroptera).

Sotero-Caio CG, Volleth M, Gollahon LS, Fu B, Cheng W, Ng BL, Yang F, Baker RJ.

BMC Evol Biol. 2013 Dec 26;13:276. doi: 10.1186/1471-2148-13-276.

11.

Mitotic perturbations induced by Nek2 overexpression require interaction with TRF1 in breast cancer cells.

Lee J, Gollahon L.

Cell Cycle. 2013 Dec 1;12(23):3599-614. doi: 10.4161/cc.26589. Epub 2013 Sep 30.

12.

Paclitaxel attenuates Bcl-2 resistance to apoptosis in breast cancer cells through an endoplasmic reticulum-mediated calcium release in a dosage dependent manner.

Pan Z, Gollahon L.

Biochem Biophys Res Commun. 2013 Mar 15;432(3):431-7. doi: 10.1016/j.bbrc.2013.01.130. Epub 2013 Feb 13.

PMID:
23415863
13.

Nek2-targeted ASO or siRNA pretreatment enhances anticancer drug sensitivity in triple‑negative breast cancer cells.

Lee J, Gollahon L.

Int J Oncol. 2013 Mar;42(3):839-47. doi: 10.3892/ijo.2013.1788. Epub 2013 Jan 22.

14.

Taxol directly induces endoplasmic reticulum-associated calcium changes that promote apoptosis in breast cancer cells.

Pan Z, Gollahon L.

Breast J. 2011 Jan-Feb;17(1):56-70. doi: 10.1111/j.1524-4741.2010.00988.x. Epub 2010 Nov 15.

PMID:
21073601
15.

Recognition and capture of breast cancer cells using an antibody-based platform in a microelectromechanical systems device.

Du Z, Cheng KH, Vaughn MW, Collie NL, Gollahon LS.

Biomed Microdevices. 2007 Feb;9(1):35-42.

PMID:
17103049
16.

Cell detachment model for an antibody-based microfluidic cancer screening system.

Wankhede SP, Du Z, Berg JM, Vaughn MW, Dallas T, Cheng KH, Gollahon L.

Biotechnol Prog. 2006 Sep-Oct;22(5):1426-33.

PMID:
17022683
17.

Microfluidic-based diagnostics for cervical cancer cells.

Du Z, Colls N, Cheng KH, Vaughn MW, Gollahon L.

Biosens Bioelectron. 2006 Apr 15;21(10):1991-5. Epub 2005 Oct 19.

PMID:
16242927
18.

Telomerase protects cancer-prone human cells from chromosomal instability and spontaneous immortalization.

Elmore LW, Turner KC, Gollahon LS, Landon MR, Jackson-Cook CK, Holt SE.

Cancer Biol Ther. 2002 Jul-Aug;1(4):391-7.

PMID:
12432253
19.

Alternative methods of extracting telomerase activity from human tumor samples.

Gollahon LS, Holt SE.

Cancer Lett. 2000 Oct 31;159(2):141-9.

PMID:
10996725
20.

Erwinia chrysanthemi strains cause death of human gastrointestinal cells in culture and express an intimin-like protein.

Duarté X, Anderson CT, Grimson M, Barabote RD, Strauss RE, Gollahon LS, San Francisco MJ.

FEMS Microbiol Lett. 2000 Sep 1;190(1):81-6.

21.

Clonal heterogeneity in telomerase activity and telomere length in tumor-derived cell lines.

Savre-Train I, Gollahon LS, Holt SE.

Proc Soc Exp Biol Med. 2000 Apr;223(4):379-88.

PMID:
10721008
22.

Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer.

Gazdar AF, Kurvari V, Virmani A, Gollahon L, Sakaguchi M, Westerfield M, Kodagoda D, Stasny V, Cunningham HT, Wistuba II, Tomlinson G, Tonk V, Ashfaq R, Leitch AM, Minna JD, Shay JW.

Int J Cancer. 1998 Dec 9;78(6):766-74.

23.

Telomerase activity during spontaneous immortalization of Li-Fraumeni syndrome skin fibroblasts.

Gollahon LS, Kraus E, Wu TA, Yim SO, Strong LC, Shay JW, Tainsky MA.

Oncogene. 1998 Aug 13;17(6):709-17.

24.

Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma.

Yashima K, Milchgrub S, Gollahon LS, Maitra A, Saboorian MH, Shay JW, Gazdar AF.

Clin Cancer Res. 1998 Jan;4(1):229-34.

25.

Detection of telomerase activity in breast masses by fine-needle aspiration.

Pearson AS, Gollahon LS, O'Neal NC, Saboorian H, Shay JW, Fahey TJ 3rd.

Ann Surg Oncol. 1998 Mar;5(2):186-93.

PMID:
9527273
26.

Genomic instability and telomerase activity in human bronchial epithelial cells during immortalization by human papillomavirus-16 E6 and E7 genes.

Coursen JD, Bennett WP, Gollahon L, Shay JW, Harris CC.

Exp Cell Res. 1997 Aug 25;235(1):245-53.

PMID:
9281374
27.

Immortalization of human mammary epithelial cells transfected with mutant p53 (273his).

Gollahon LS, Shay JW.

Oncogene. 1996 Feb 15;12(4):715-25.

PMID:
8632893
28.

p53 levels in human mammary epithelial cells expressing wild-type and mutant human papillomavirus type 16 (HPV-16) E6 proteins.

Holt S, Gollahon L, Willingham T, Barbosa M, Shay J.

Int J Oncol. 1996 Feb;8(2):263-70.

PMID:
21544354
29.

Telomerase activity in human breast tumors.

Hiyama E, Gollahon L, Kataoka T, Kuroi K, Yokoyama T, Gazdar AF, Hiyama K, Piatyszek MA, Shay JW.

J Natl Cancer Inst. 1996 Jan 17;88(2):116-22.

PMID:
8537972
30.

Loss of heterozygosity at chromosome 1q loci in rat mammary tumors.

Gollahon LS, Chen A, Aldaz CM.

Mol Carcinog. 1995 Jan;12(1):7-13.

PMID:
7818765
31.

Spontaneous in vitro immortalization of breast epithelial cells from a patient with Li-Fraumeni syndrome.

Shay JW, Tomlinson G, Piatyszek MA, Gollahon LS.

Mol Cell Biol. 1995 Jan;15(1):425-32.

32.

Hepatocyte growth factor (HGF), keratinocyte growth factor (KGF), and their receptors in human breast cells and tissues: alternative receptors.

Wilson SE, Weng J, Chwang EL, Gollahon L, Leitch AM, Shay JW.

Cell Mol Biol Res. 1994;40(4):337-50. Erratum in: Cell Mol Biol Res 1994;40(7-8):707.

PMID:
7866434
33.
34.

Nonrandom abnormalities involving chromosome 1 and Harvey-ras-1 alleles in rat mammary tumor progression.

Aldaz CM, Chen A, Gollahon LS, Russo J, Zappler K.

Cancer Res. 1992 Sep 1;52(17):4791-8.

35.

Chromosome alterations in rat mammary tumor progression.

Aldaz CM, Gollahon LS, Chen A.

Prog Clin Biol Res. 1992;376:137-53. Review. No abstract available.

PMID:
1528918
36.

Chromosomal localization of the rat Harvey-ras-1 gene (HRAS) by in situ hybridization.

Gollahon LS, Aldaz CM.

Cytogenet Cell Genet. 1992;61(2):123-4.

PMID:
1395719

Supplemental Content

Loading ...
Support Center